Mice Model Market Introduction

Mice models, also known as mouse models, are widely used in medical and biological research to study human diseases and develop new treatments. Mice models are genetically engineered or bred to mimic specific human diseases or traits, such as cancer, Alzheimer's disease, diabetes, and obesity. They are also used to study basic biological processes, such as development, behavior, and genetics.Mice models are highly preferred over other animal models because they are small, easy to handle, and have a short reproductive cycle. Additionally, they share many physiological and genetic similarities with humans, making them ideal for studying human diseases and developing new therapies.The mice model market includes several types of models, including inbred, outbred, genetically engineered, and hybrid models. These models can be further classified based on their application, such as oncology, immunology, neurology, and metabolic disorders.The mice model market is highly competitive, with several key players, such as Charles River Laboratories, The Jackson Laboratory, and Taconic Biosciences, dominating the market. The market is also influenced by various factors, such as increasing research and development activities, growing demand for personalized medicine, and advancements in gene-editing technologies.

Mice Model Market Size

The global mice model market size was valued at approximately USD 1.1 billion in 2020 and was expected to grow at a compound annual growth rate (CAGR) of around 6.7% from 2021 to 2028.The mice model market is driven by several factors, including the growing demand for personalized medicine, the increasing focus on research activities in the field of genetics and genomics, and the rising prevalence of cancer and infectious diseases. The pharmaceutical and biotechnology industries are the major end-users of mice models for drug discovery and development.The Asia Pacific region is expected to witness significant growth during the forecast period due to the increasing investments in research and development activities in countries such as China, India, and Japan.However, it is important to note that market sizes and growth rates can be subject to fluctuations and changes over time, and may be affected by various economic, technological, and regulatory factors.

Mice Model Market Share

The global mice model market size is expected to reach USD 1.59 billion by 2023, growing at a CAGR of 6.3% during the forecast period.In terms of type, the genetically engineered mice models segment holds the largest share of the market due to their ability to mimic human diseases and traits accurately. The inbred mice models segment is also a significant contributor to the market share due to their use in basic research and drug discovery.Based on application, oncology holds the largest market share due to the increasing prevalence of cancer and the high demand for effective cancer therapies. The neurology segment is also expected to see significant growth due to the rising incidence of neurological disorders and the development of advanced gene-editing technologies.Geographically, North America holds the largest market share, followed by Europe and the Asia Pacific. The dominance of North America is due to the presence of several key players in the region, well-established research infrastructure, and high funding for research activities. The Asia Pacific region is expected to witness significant growth during the forecast period due to increasing investments in research and development activities and the growing demand for personalized medicine.In summary, the mice model market is expected to see significant growth in the coming years, driven by the increasing demand for effective therapies for various diseases and the development of advanced gene-editing technologies. The market is highly competitive, with key players focusing on research and development activities and strategic collaborations to maintain their market position.

Mice Model Market Trends

There are several trends that are currently shaping the global mice model market. Some of the key trends are:Growing demand for precision medicine: The increasing focus on precision medicine and personalized treatment options is driving the demand for mice models for research and drug discovery activities.Increasing adoption of CRISPR technology: The adoption of CRISPR gene-editing technology is gaining momentum in the mice model market as it allows researchers to create genetically modified mice models with greater accuracy and efficiency.Rising use of humanized mice models: The use of humanized mice models is increasing as they allow for more accurate and efficient testing of human-specific diseases and disorders.Growing focus on 3D cell culture technology: The adoption of 3D cell culture technology is increasing in the mice model market as it enables researchers to mimic the in vivo environment more accurately, leading to more accurate and reliable research results.Increasing popularity of contract research organizations (CROs): The demand for contract research organizations is increasing as they provide customized mice models for specific research requirements, thereby reducing the overall cost and time required for research.

Overall, these trends are expected to continue shaping the mice model market in the coming years, leading to more innovative and efficient research tools and technologies.

Mice Model Market Driving Factors

There are several factors driving the growth of the mice model market. These include:Increasing demand for personalized medicine: Personalized medicine is a growing field that seeks to tailor treatments to the specific needs of individual patients. Mice models are a key tool in the development of personalized medicine as they allow researchers to study the effects of drugs on specific genetic mutations or disease states.Growing prevalence of chronic diseases: Chronic diseases such as cancer, cardiovascular disease, and diabetes are on the rise globally. Mice models provide a valuable tool for studying the underlying mechanisms of these diseases and developing new treatments.Advancements in gene-editing technologies: Gene-editing technologies such as CRISPR-Cas9 have revolutionized the field of mice model research. These technologies allow for precise modification of the mouse genome, enabling researchers to create models that more accurately mimic human diseases.Increasing funding for research activities: Government and private funding for research activities is on the rise, particularly in the areas of biomedical research and drug development. This has led to increased investment in mice model research and the development of new and innovative models.Rising demand for humanized mice models: Humanized mice models are mice that have been genetically engineered to have human cells or tissues, making them a valuable tool for studying human diseases and drug development. The increasing demand for humanized mice models is driving growth in the mice model market.In summary, the mice model market is being driven by a range of factors, including the growing demand for personalized medicine, the increasing prevalence of chronic diseases, advancements in gene-editing technologies, rising funding for research activities, and the rising demand for humanized mice models.

Mice Model Market Regional Analysis

The mice model market can be analyzed on a regional basis, with some of the major regions being North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.North America and Europe are the major markets for mice models, primarily due to the presence of established pharmaceutical and biotechnology industries and well-developed research infrastructure. The presence of leading players in the market and the availability of funding for research activities also contribute to the growth of the market in these regions.The Asia Pacific region is expected to witness significant growth during the forecast period due to the increasing investments in research and development activities and the growing focus on the development of innovative therapies. Additionally, the region has a large pool of patients and growing awareness regarding the importance of personalized medicine, leading to a rise in demand for mice models.Latin America and the Middle East & Africa regions are also expected to witness growth in the mice model market due to increasing investments in research and development activities and the growing prevalence of chronic diseases.Overall, the regional analysis of the mice model market reveals the presence of various growth opportunities and challenges, which can be attributed to the differences in economic, technological, and regulatory factors across different regions.

Mice Model Market Forecasts 2030 

The global mice model market was expected to grow at a compound annual growth rate (CAGR) of around 6.7% from 2021 to 2028.Factors such as the increasing demand for personalized medicine, rising investments in research and development activities, growing focus on genetics and genomics, and the prevalence of chronic diseases are expected to drive the growth of the market during the forecast period. Additionally, the adoption of new technologies such as CRISPR gene-editing technology and 3D cell culture technology is expected to further boost the growth of the market.The Asia Pacific region is expected to witness the highest growth during the forecast period due to increasing investments in research and development activities, growing awareness regarding the importance of personalized medicine, and a large patient population. However, the market may also face challenges such as ethical concerns regarding the use of animals for research purposes and the high cost associated with the maintenance and care of mice models.It is important to note that market forecasts can be subject to fluctuations and changes over time, and may be affected by various economic, technological, and regulatory factors. Therefore, it is advisable to consult with industry experts and conduct thorough market research before making any investment decisions.

Mice Model Market Key Industry Players

The mice model market is highly competitive, with several key players dominating the market. Some of the leading players in the industry include:

Charles River Laboratories International, Inc.

The Jackson Laboratory

Taconic Biosciences, Inc.

Envigo

Laboratory Corporation of America Holdings (LabCorp)

JANVIER LABS

genOway S.A.

Horizon Discovery Group plc

Trans Genic Inc.

Crown Bioscience, Inc.

These companies offer a range of mice models for various applications and provide a wide range of services, including breeding and cryopreservation, genotyping, and phenotyping. Many of these companies also offer custom model creation services to meet the specific needs of researchers.In addition to these key players, there are also several smaller companies and academic institutions that are active in the mice model market. These companies often specialize in niche areas, such as rare disease models or specialized strains, and can offer unique models and services to researchers.Overall, the mice model market is highly competitive, with key players focusing on research and development activities, strategic collaborations, and acquisitions to maintain their market position.